Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ARG1 | P05089 | 1/20 | 0.48 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | CA6 | P23280 | 1/20 | 0.44 |
| ▸ | APP | P05067 | 3/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.43 |
| ▸ | MAPT | P10636 | 4/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | THPO | P40225 | 1/20 | 0.43 |
| ▸ | TOP1 | P11387 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | HPGD | P15428 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL28351801 | 0.97 | ARG1 (0.47) | ARG1TRPA1CA1CA2CA4 | |
| Hydrochloric Acid SCHEMBL27786790 | 0.97 | ARG1 (0.47) | ARG1TRPA1CA1CA2CA4 | |
| Protocatechuic Acid SCHEMBL4531319 | 0.82 | CA12 (0.68) | CA1CA2CA4CA6MAPT | |
| SCHEMBL9769481 | 0.80 | IDO1 (0.48) | CA1CA2APPHSD17B10MAPT | |
| SCHEMBL8350047 | 0.80 | TP53 (0.52) | APPHSD17B10MAPTALOX15HIF1A | |
| SCHEMBL2195425 | 0.80 | IDO1 (0.48) | CA1CA2APPHSD17B10MAPT | |
| SCHEMBL3963262 | 0.80 | ALDH1A1 (0.50) | TRPA1APPHSD17B10MAPTALOX15 | |
| SCHEMBL10001895 | 0.78 | HSD17B10 (0.50) | CA1CA2HSD17B10MAPTALOX15 | |
| SCHEMBL20895803 | 0.78 | TP53 (0.39) | ARG1TRPA1CA1CA2APP | |
| SCHEMBL1487928 | 0.78 | TNIK (0.41) | CA1CA2CA6APPHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103435829-A | Nanometer functionalization surface modification method based on o-dihydroxybenzene derivatives | YANTAI LVSHUIFU MEMBRANE MATERIAL LTD | 2013-12-11 | — | — | CN | claimed |
| CN-102373193-A | Microbial cell immobilizing carrier and related application | UNIV EAST CHINA SCIENCE & TECH | 2012-03-14 | — | — | CN | claimed |
| WO-2024135708-A1 | METHOD FOR PRODUCING COMPOUND, POLYMER, COMPOSITION, AND PATTERN FORMATION METHOD | 三菱瓦斯化学株式会社 | 2024-06-27 | — | — | WO | disclosed |
| US-20230348351-A1 | COMPOUND, POLYMER, COMPOSITION, COMPOSITION FOR FILM FORMATION, PATTERN FORMATION METHOD, INSULATING FILM FORMATION METHOD, AND METHOD FOR PRODUCING COMPOUND | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2023-11-02 | — | — | US | disclosed |
| EP-3596067-B1 | PYRAZOLE DERIVATIVES FOR THE TREATMENT OF CYSTIC FIBROSIS | FONDAZIONE ST ITALIANO TECNOLOGIA (IT) | 2023-06-07 | — | — | EP | disclosed |
| CN-110621654-B | TRPV1 modulator compounds | 安塔尔遗传学公司 | 2022-11-01 | — | — | CN | disclosed |
| US-10870646-B2 | Oxazolidinones and pharmaceutical compositions thereof for treating bacterial infections, including infection of Mycobacterium tuberculosis | UNIVERSITY OF ST. THOMAS (US) | 2020-12-22 | — | — | US | disclosed |
| WO-2020138404-A1 | METHOD FOR PRODUCING NANOPARTICLES INCLUDING METAL PARTICLES CONTAINING IRON OXIDE HAVING AT LEAST ONE HYDROPHILIC LIGAND COORDINATED THERETO | アステラス製薬株式会社 | 2020-07-02 | — | — | WO | disclosed |
| WO-2017218499-A1 | IONIC POLYMERS AND THEIR USE AS WET-ADHESIVES AND COATINGS | ACatechol, Inc. (US) | 2017-12-21 | — | — | WO | disclosed |
| WO-2017168024-A1 | COMPOUNDS WITH ANTIOXIDANT ACTIVITY AND USES THEREOF | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC) (ES) | 2017-10-05 | — | — | WO | disclosed |
| EP-2718379-B1 | BOTTOM ANTIREFLECTIVE COATING COMPOSITIONS AND PROCESSES THEREOF | MERCK PATENT GMBH (DE) | 2016-08-17 | — | — | EP | disclosed |
| EP-0706551-A1 | POLYALKYL HYDROXY AND AMINO AROMATIC CARBAMATES AND FUEL COMPOSITIONS CONTAINING THE SAME | CHEVRON CHEMICAL COMPANY (US) | 1996-04-17 | — | — | EP | disclosed |
| US-5484463-A | Poly(oxyalkylene) hydroxy and amino aromatic carbamates and fuel compositions containing the same | CHEVRON CHEMICAL COMPANY (US) | 1996-01-16 | — | — | US | disclosed |
| WO-1995029971-A1 | MANNICH CONDENSATION PRODUCTS OF POLY(OXYALKYLENE) HYDROXYAROMATIC CARBAMATES AND FUEL COMPOSITIONS CONTAINING THE SAME | CHEVRON CHEMICAL COMPANY (US) | 1995-11-09 | — | — | WO | disclosed |
| WO-1995029975-A1 | POLY(OXYALKYLENE) HYDROXY AND AMINO AROMATIC CARBAMATES AND FUEL COMPOSITIONS CONTAINING THE SAME | CHEVRON CHEMICAL COMPANY (US) | 1995-11-09 | — | — | WO | disclosed |
| WO-1995029972-A1 | POLYALKYL HYDROXY AND AMINO AROMATIC CARBAMATES AND FUEL COMPOSITIONS CONTAINING THE SAME | CHEVRON CHEMICAL COMPANY (US) | 1995-11-09 | — | — | WO | disclosed |
| US-5413615-A | Fuel additives, antideposit | CHEVRON CHEMICAL COMPANY (US) | 1995-05-09 | — | — | US | disclosed |
| US-5413614-A | Antideposit | CHEVRON CHEMICAL COMPANY (US) | 1995-05-09 | — | — | US | disclosed |
| US-4212645-A | Hair dyeing composition containing an aryldiamine and a substituted catechol | LEVER BROTHERS COMPANY (US) | 1980-07-15 | — | — | US | disclosed |
| US-4022878-A | NATIVE HOMOLOGOUS HAPTEN OR ANTIGEN | BIOLOGICAL DEVELOPMENTS, INC. (US) | 1977-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230348351-A1 | COMPOUND, POLYMER, COMPOSITION, COMPOSITION FOR FILM FORMATION, PATTERN FORMATION METHOD, INSULATING FILM FORMATION METHOD, AND METHOD FOR PRODUCING COMPOUND | PHOSPHO1, RER1, RIF1 | ARG1 1090/4885TRPA1 3551/4885CA1 205/4885 |
| US-10870646-B2 | Oxazolidinones and pharmaceutical compositions thereof for treating bacterial infections, including infection of Mycobacterium tuberculosis | OXA1L, IMMT, TBCD | ARG1 296/4885TRPA1 3572/4885CA1 4829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.